Skip to main content
Clinical Trials/NCT02751723
NCT02751723
Unknown
Not Applicable

Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease

Florian Lordick, MD21 sites in 1 country500 target enrollmentSeptember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer Disease, Palliative Therapy
Sponsor
Florian Lordick, MD
Enrollment
500
Locations
21
Primary Endpoint
Change from Baseline Patient´s answers regarding symptom burden at 12 months
Last Updated
7 years ago

Overview

Brief Summary

The aim of this non-investigational study is to determine the symptoms and disease burden at the time point of diagnosis and in the further course of an incurable cancer disease. The needs and preferences of patients suffering from cancer (ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer) are examined by various validated questionnaires. The data obtained by these questionnaires are collected together with information obtained by the treating physicians at four time points during the study: t0 - patient´s enrollment, at the moment of diagnosis and before the start of tumor therapy, respectively; T1 - 3 months after patient´s enrollment; T2 - 6 months after patient´s enrollment; T3 - 12 months after patient´s enrollment. This highly innovative project offers the chance to identify medical services deficits and risk circumstances for the burden of treatments in an oncology-palliative setting and to optimize the quality of patient care.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
October 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Florian Lordick, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Florian Lordick, MD

Prof. Dr. med. (MD, PhD)

University of Leipzig

Eligibility Criteria

Inclusion Criteria

  • Incurable cancer disease: ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer
  • signed and dated Inform Consent Form
  • Age ≥ 18 years

Exclusion Criteria

  • Patient is not able to understand and to answer questions
  • Patient is in a critical health situation and is directly threatened due to cancer disease or the resulting complications

Outcomes

Primary Outcomes

Change from Baseline Patient´s answers regarding symptom burden at 12 months

Time Frame: 12 months after enrollment

Secondary Outcomes

  • Change from Baseline Patient´s answers regarding symptom burden at 3 months(3 months after enrollment)
  • Change from Baseline physician´s report at 3 months(3 months after enrollment)
  • Change from Baseline physician´s report at 6 months(6 months after enrollment)
  • Change from Baseline physician´s report at 12 months(12 months after enrollment)
  • Change from Baseline Patient´s answers regarding symptom burden at 6 months(6 months after enrollment)

Study Sites (21)

Loading locations...

Similar Trials